AMBERSTONE BIOSCIENCES
Amberstone Biosciences discovers novel immunotherapies through innovative technologies and creative partnerships. Amberstone's focus is difficult targets requiring a unique mode-of-action and/or particular functional property, which are otherwise challenging for traditional approaches. These conventional limitations are overcome via a two-pronged approach. First, we have demonstrated success with our microfluidics-powered AmberFlow drug-discovery platform. Second, our team of experts has keen insights in immuno-oncology and ample experience with single-cell assay biology.
AMBERSTONE BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2016-01-01
Address:
Laguna Hills, California, United States
Country:
United States
Website Url:
http://www.amberstonebio.com
Total Employee:
11+
Status:
Active
Contact:
9492697918
Email Addresses:
[email protected]
Total Funding:
13.28 M USD
Technology used in webpage:
Euro Google
Similar Organizations
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Employees Featured
Founder
Investors List
Xiamen Changrong Investment Management
Xiamen Changrong Investment Management investment in Series A - Amberstone Biosciences
Viva BioInnovator
Viva BioInnovator investment in Series A - Amberstone Biosciences
Sinovation Ventures
Sinovation Ventures investment in Series A - Amberstone Biosciences
Cowin Venture
Cowin Venture investment in Series A - Amberstone Biosciences
Lifespan Investments
Lifespan Investments investment in Series A - Amberstone Biosciences
National Science Foundation
National Science Foundation investment in Grant - Amberstone Biosciences
National Science Foundation
National Science Foundation investment in Grant - Amberstone Biosciences
Official Site Inspections
http://www.amberstonebio.com
Unable to get host informations!!!
More informations about "Amberstone Biosciences"
About – Amberstone Biosciences Inc.
15300 Barranca Pkwy, Suite 100, Irvine CA 92618, United States. Email: [email protected] Phone: +1 (949) 331-3934See details»
Amberstone Biosciences - Crunchbase Company Profile & Funding
Organization. Amberstone Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
Amberstone Biosciences - PitchBook
Jan 3, 2022 Amberstone Biosciences General Information Description. Developer of transformative therapeutic antibodies designed to benefit patients with unmet medical needs. The company's therapeutic antibodies use a …See details»
Amberstone Biosciences - LinkedIn
Amberstone Biosciences, Inc. is an early-stage biotechnology company focused on developing next-generation T cell engagers (TCEs) for the treatment of solid tumors.See details»
Amberstone Biosciences Announces Formation of …
LAGUNA HILLS, Calif., June 27, 2022 /PRNewswire/ -- Amberstone Biosciences (www.amberstonebio.com), an emerging biotech company with expertise in developing a new generation of cancer therapeutics ...See details»
Amberstone Biosciences Announces Formation of Scientific
LAGUNA HILLS, Calif., June 27, 2022 /PRNewswire/ -- Amberstone Biosciences (www.amberstonebio.com), an emerging biotech company with expertise in developing a new …See details»
Amberstone Biosciences Secures $12 Million Series A …
Jan 3, 2022 For more information, please visit www.amberstonebio.com. About Viva BioInnovator. As the venture arm of Viva Biotech Holdings (1873.HK), Viva BioInnovator is dedicated to investing globally in ...See details»
Amberstone Biosciences - Craft
Amberstone Biosciences is a biotechnology company developing tumor-activated immunotherapeutics. It utilizes the T-MATE technology to offer a solution that triggers immune …See details»
Science – Amberstone Biosciences Inc.
15300 Barranca Pkwy, Suite 100, Irvine CA 92618, United States. Email: [email protected] Phone: +1 (949) 331-3934See details»
Amberstone Biosciences - Viva BioInnovator
Www.amberstonebio.com. location. USA, California, Laguna Hills. modality. Macro Molecule. Indications. Oncology. Amberstone Biosciences is an emerging biotherapeutics company …See details»
Amberstone Biosciences Secures $12 Million Series A Financing to ...
LAGUNA HILLS, Calif., January 3, 2022-- Amberstone Biosciences (www.amberstonebio.com), an emerging biotherapeutics company with unique expertise in conditionally active …See details»
Amberstone Biosciences Raise $12M for Tumor Therapy Programs
Jul 9, 2024 Biotech startup company Amberstone Biosciences announced today that it raised $12 million in a Series A business funding round led by Viva BioInnovator, Co-win Ventures, …See details»
Amberstone Biosciences Secures $12 Million Series A ... - BioSpace
Jan 3, 2022 LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Amberstone Biosciences (www.amberstonebio.com), an emerging biotherapeutics company with unique expertise in …See details»
Amberstone Biosciences Announces Formation of Scientific …
LAGUNA HILLS, Calif., June 27, 2022 /PRNewswire/ -- Amberstone Biosciences (www.amberstonebio.com), an emerging biotech company with expertise in ...See details»
Amberstone Biosciences Secures $12 Million Series A Financing to ...
Jan 3, 2022 LAGUNA HILLS, CA, USA I January 03, 2021 I Amberstone Biosciences (www.amberstonebio.com), an emerging biotherapeutics company with unique expertise in …See details»
Amberstone Biosciences Secures $12 Million Series A Financing to ...
Jan 3, 2022 Amberstone Biosciences (www.amberstonebio.com), an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, today announced …See details»
Pipeline – Amberstone Biosciences Inc.
Driven by a proprietary integrated discovery platform comprising innovative microfluidics-based single-cell screening system, molecular evolution, CADD, AI/ML and beyondSee details»
Amberstone Biosciences Emerges with $12 Million for Solid
Jan 3, 2022 With $12 million in hand from a Series A investment round, California-based Amberstone Biosciences is taking aim at cancer with its highly-differentiated tumor …See details»